ArticleEClinicalMedicine2023

Safety and performance of the third-generation drug-eluting resorbable coronary magnesium scaffold system in the treatment of subjects with de novo coronary artery lesions: 6-month results of the prospective, multicenter BIOMAG-I first-in-human study.

Michael Haude et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.